Acetylsalicylic acid Completed Phase 3 Trials for High Risk Essential Thrombocythemia / High Risk Polycythemia Vera Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01259856Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)